Want to join the conversation?
In FY17, $MDT expects constant currency revenue growth to be in the upper-half of the mid-single digit range of 5-6%. The company expects non-GAAP diluted EPS to be in the range of $4.60-4.70, including an expected $0.20-0.25 negative foreign currency impact based on current exchange rates.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.